Guobang Pharma Ltd.
SSE:605507.SS
20.53 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 1,909.317 | 2,094.159 | 1,973.992 | 893.006 | 1,234.603 | 1,114.811 | 1,001.921 | 946.144 |
| Short Term Investments
| 617.664 | 465.987 | 824.559 | 1,258.257 | 0.035 | 149.873 | 0 | 0 |
| Cash and Short Term Investments
| 2,526.981 | 2,560.146 | 2,798.55 | 2,151.264 | 1,234.638 | 1,264.684 | 1,001.921 | 946.144 |
| Net Receivables
| 1,349.858 | 1,021.97 | 775.341 | 571.499 | 544.513 | 521.253 | 515.426 | 548.357 |
| Inventory
| 1,363.411 | 1,368.557 | 1,409.204 | 1,309.329 | 989.545 | 846.729 | 868.934 | 616.416 |
| Other Current Assets
| 634.049 | 516.716 | 146.223 | 41.106 | 102.396 | 127.764 | 454.993 | 314.241 |
| Total Current Assets
| 5,874.3 | 5,443.147 | 5,129.319 | 4,567.298 | 2,871.167 | 2,760.431 | 2,832.492 | 2,425.157 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 4,343.657 | 4,330.044 | 3,283.516 | 2,621.964 | 2,152.098 | 1,455.872 | 1,178.85 | 1,113.201 |
| Goodwill
| 0.025 | 0.025 | 0.025 | 0.025 | 0.025 | 0.025 | 0.025 | 0 |
| Intangible Assets
| 350.835 | 358.847 | 370.496 | 272.265 | 266.706 | 274.541 | 156.385 | 129.666 |
| Goodwill and Intangible Assets
| 350.86 | 358.873 | 370.522 | 272.29 | 266.732 | 274.566 | 156.41 | 129.666 |
| Long Term Investments
| -505.09 | -344.86 | -723.192 | -1,241.145 | 18.638 | -129.875 | 142.109 | 316.149 |
| Tax Assets
| 8.96 | 7.778 | 6.586 | 19.017 | 12.011 | 11.917 | 20.013 | 13.595 |
| Other Non-Current Assets
| 707.75 | 566.653 | 976.433 | 1,273.648 | 187.929 | 386.475 | 36.815 | 26.416 |
| Total Non-Current Assets
| 4,906.136 | 4,918.488 | 3,913.865 | 2,945.774 | 2,637.408 | 1,998.955 | 1,534.198 | 1,599.026 |
| Total Assets
| 10,780.436 | 10,361.635 | 9,043.185 | 7,513.072 | 5,508.575 | 4,759.386 | 4,366.69 | 4,024.183 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 1,703.674 | 1,714.612 | 974.347 | 789.707 | 1,095.742 | 920.704 | 907.573 | 901.586 |
| Short Term Debt
| 175.134 | 492.751 | 655.57 | 160.166 | 509.407 | 446.501 | 553.373 | 655.496 |
| Tax Payables
| 49.887 | 34.227 | 17.989 | 43.312 | 34.652 | 38.462 | 92.202 | 85.156 |
| Deferred Revenue
| 0 | 55.849 | 52.791 | 200.389 | 214.062 | 200.19 | 92.202 | 184.75 |
| Other Current Liabilities
| 629.092 | 127.269 | 214.476 | 129.65 | 290.177 | 153.069 | 70.561 | 169.71 |
| Total Current Liabilities
| 2,557.787 | 2,449.622 | 1,862.382 | 1,153.51 | 1,972.465 | 1,573.841 | 1,715.91 | 1,811.948 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 146.721 | 451.7 | 0 | 0 | 251 | 482.66 | 27 | 0 |
| Deferred Revenue Non-Current
| 16.674 | 11.8 | 14.267 | 9.708 | 8.272 | 9.307 | 10.343 | 4.035 |
| Deferred Tax Liabilities Non-Current
| 7.197 | 11.325 | 11.931 | 4.161 | 2.69 | 3.352 | 2.862 | 0.861 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 74.366 | 28.462 | 0 |
| Total Non-Current Liabilities
| 170.592 | 474.825 | 26.198 | 13.869 | 261.962 | 569.685 | 58.645 | 4.897 |
| Total Liabilities
| 2,728.379 | 2,924.447 | 1,888.58 | 1,167.379 | 2,234.427 | 2,143.526 | 1,774.555 | 1,816.845 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 558.824 | 558.824 | 558.824 | 558.824 | 475 | 475 | 75.972 | 75.972 |
| Retained Earnings
| 3,668.302 | 3,082.29 | 2,846.488 | 2,055.271 | 1,728.003 | 1,075.206 | 1,101.477 | 936.423 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 3,749.944 | 124.541 | 50.382 | 1,066.527 | 70.614 | 0 |
| Other Total Stockholders Equity
| 3,820.215 | 3,790.92 | 3,749.944 | 3,731.985 | 1,021.348 | 1,066.527 | 20.676 | 67.084 |
| Total Shareholders Equity
| 8,047.34 | 7,432.034 | 7,155.256 | 6,346.079 | 3,274.733 | 2,616.733 | 1,248.063 | 1,079.48 |
| Total Equity
| 8,052.057 | 7,437.189 | 7,154.605 | 6,345.694 | 3,274.148 | 2,615.859 | 2,592.134 | 2,207.339 |
| Total Liabilities & Shareholders Equity
| 10,780.436 | 10,361.635 | 9,043.185 | 7,513.072 | 5,508.575 | 4,759.386 | 4,366.69 | 4,024.183 |